Antioxidant and renal protective effects of Nano-selenium on adenine-induced acute renal failure in canines

Mengdi Zhang1, Jindong Gao2, Md F Kulyar3

  • 1Engineering Laboratory for Tarim Animal Diseases Diagnosis and Control/College of Animal Science, Tarim University, Alar, Xinjiang 843300, China; College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China.

Insights

Nano-selenium effectively treats acute renal failure in dogs by improving kidney function and boosting antioxidant levels. It works by activating the Keap1-Nrf2/ARE pathway, enhancing the body's resistance to disease.

Area of Science:

  • Veterinary Medicine
  • Biochemistry
  • Toxicology

Background:

  • Acute renal failure (ARF) is a prevalent condition in canines, characterized by impaired kidney function and reduced antioxidant capacity.
  • ARF negatively impacts canine health, decreasing their overall resistance to disease and leading to significant clinical complications.

Purpose of the Study:

  • To investigate the therapeutic effects and underlying mechanisms of nano-selenium in treating canine acute renal failure.
  • To evaluate how nano-selenium influences key biomarkers of kidney function, oxidative stress, and the Keap1-Nrf2/ARE signaling pathway in canine ARF.

Main Methods:

  • Histopathological and imaging analyses were performed on kidney tissues to assess structural changes.
  • Blood and kidney tissue levels of creatinine (CRE) and blood urea nitrogen (BUN) were measured.
  • Activities of antioxidant enzymes like glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD), and malondialdehyde (MDA) levels were assessed.
  • Gene and protein expression of Keap1, Nrf2, HO-1, and NQO1 were analyzed using RT-qPCR, Western blot, and immunohistochemistry.

Main Results:

  • Nano-selenium administration significantly reduced CRE and BUN concentrations in blood and kidney tissues.
  • Treatment with nano-selenium increased GSH-PX and SOD activities while decreasing MDA levels, indicating reduced oxidative stress.
  • Histopathological and imaging findings demonstrated structural improvements in kidney tissues affected by ARF.
  • Nano-selenium significantly downregulated Keap1 mRNA expression and upregulated Nrf2, HO-1, and NQO1 mRNA expression, confirmed at the protein level.

Conclusions:

  • Nano-selenium demonstrates significant therapeutic potential for canine acute renal failure.
  • The mechanism involves the modulation of the Keap1-Nrf2/ARE signaling pathway, leading to enhanced antioxidant defense and improved kidney function.
  • Nano-selenium intervention offers a promising strategy to bolster antioxidant levels and improve kidney health in affected canines.